Hamda A. Qotba
Doha, DA, Qatar
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Prevalence, patterns, drivers, and perceived benefits of herbal medicine use in COVID-19 patients in Qatar.
Journal: Journal of pharmaceutical policy and practice
Published: July 25, 2025
Comprehensive analysis of human coronavirus antibody responses in ICU and non-ICU COVID-19 patients reveals IgG3 against SARS-CoV-2 spike protein as a key biomarker of disease severity.
Journal: Journal of medical microbiology
Published: May 13, 2025
SARS-CoV-2 infection triggers more potent antibody-dependent cellular cytotoxicity (ADCC) responses than mRNA-, vector-, and inactivated virus-based COVID-19 vaccines.
Journal: Journal of medical virology
Published: May 15, 2023
Children and adolescents coping with home isolation and social distancing during Covid-19 in Qatar: a cross sectional study with qualitative items.
Journal: BMC psychology
Published: January 23, 2023
Assessment of Indoor Air Quality of Four Primary Health Care Centers in Qatar.
Journal: Microorganisms
Published: August 28, 2022
Neutralizing antibodies against SARS-CoV-2 are higher but decline faster in mRNA vaccinees compared to individuals with natural infection.
Journal: Journal of travel medicine
Published: August 23, 2022
Bacterial indoor air contaminations in hospitals in MENA region: a systematic review.
Journal: International journal of environmental health research
Published: June 06, 2022
Evaluation of commercially available fully automated and ELISA-based assays for detecting anti-SARS-CoV-2 neutralizing antibodies.
Journal: Scientific reports
Published: June 02, 2022
Performance evaluation of novel fluorescent-based lateral flow immunoassay (LFIA) for rapid detection and quantification of total anti-SARS-CoV-2 S-RBD binding antibodies in infected individuals.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: January 05, 2022
Low Risk of Serological Cross-Reactivity between the Dengue Virus and SARS-CoV-2-IgG Antibodies Using Advanced Detection Assays.
Journal: Intervirology
Published: August 05, 2021
Can commercial automated immunoassays be utilized to predict neutralizing antibodies after SARS-CoV-2 infection? A comparative study between three different assays.
Journal: Frontiers in bioscience (Landmark edition)
Published: April 19, 2021
Analytic comparison between three high-throughput commercial SARS-CoV-2 antibody assays reveals minor discrepancies in a high-incidence population.
Journal: Scientific reports
Published: January 03, 2021
Last Updated: 09/26/2026